Clinton's Budget

Steven Benowitz's page 1 story (The Scientist, March 17, 1997) is entitled "Scientists Optimistic About Clinton's Federal R&D Budget." Which scientists? The only ones identified in the text who are not disconsolate about the Clinton budget are senior federal political appointees in various departments and agencies-Commerce, the National Science Foundation, and the Office of Science and Technology Policy-who don't get to have their own opinions (if they want to keep their jobs). The proposed

Written byHenry Miller
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Steven Benowitz's page 1 story (The Scientist, March 17, 1997) is entitled "Scientists Optimistic About Clinton's Federal R&D Budget." Which scientists? The only ones identified in the text who are not disconsolate about the Clinton budget are senior federal political appointees in various departments and agencies-Commerce, the National Science Foundation, and the Office of Science and Technology Policy-who don't get to have their own opinions (if they want to keep their jobs).

The proposed budget data reported in The Scientist indicate that while the funding of the National Institutes of Health and NSF will barely keep them even with inflation, the emphasis is strongly on applied research and development, including the marginal "research" performed by regulatory agencies. Basic research gets short shrift in spite of its stunning history of spawning whole new fields such as microelectronics and biotechnology.

The closer one looks at the Clinton budget, the more troubling the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies